Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Fennec Pharmaceuticals Inc.

NASDAQ: FENC · Life Sciences · 4 alerts · CIK 1211583

Share price
$12.76Close, Nov 16
Market cap
$450M
Shares outstanding
35.31MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Fennec Pharmaceuticals Inc. filings on SEC EDGAR ↗

4:03 PM ET 8-K
Clinical Trial Data

Fennec Pharmaceuticals Clinical Trial Data

Fennec Pharmaceuticals announced positive results from the investigator-initiated Phase 2 STS-J01 clinical study of PEDMARK in Japan for pediatric and AYA patients. The study met its primary endpoint, showing hearing loss in only 24.0% of patients compared to a historical benchmark of 56.4%, while demonstrating no interference with cisplatin antitumor activity.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.